Vascular cell adhesion molecule-1 (VCAM-1) is expressed on vascular endothelium in a variety of inflammatory conditions and mediates leukocyte recruitment from blood into tissues. In this study we report a novel role for VCAM-1 in the formation of the umbilical cord and placenta during development. The murine VCAM1 gene was disrupted by targeted homologous recombination, and a distinct phenotype was found in VCAM-l-deficient embryos. At 8.5 days of gestation, the allantois failed to fuse to the chorion, resulting in abnormal placental development and embryonic death within 1-3 days. In addition, a role for VCAM-1 in early placental formation after chorioallantoic fusion was observed. In a minority of VCAM-l-deficient embryos, the allantois was able to fuse with the chorion, but the allantoic mesoderm was abnormally distributed over the chorionic surface. A small number of VCAM-l-deficient embryos survived, presumably by circumventing the placentation defects. They became viable and fertile adult mice with lack of VCAM-1 expression, normal organs, and an elevated number of circulating blood mononuclear leukocytes.
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Vascular cell adhesion molecule-1 (VCAM-1) is a transmembrane glycoprotein member of the immunoglobulin gene superfamily (Osborn et al. 1989 ). Similarities to ICAM-1 in structure and leukocyte adhesive function provided the clue that led to identification of e~4f~l (VLA-4; CD49d/CD29) and subsequently a4137 integrins as its ligands (Elices et al. 1990; Chan et al. 1992) . Internal homology of VCAM-1 immunoglobulin-like domains (1-3 and 4-6), which likely arose by duplication of an ancestral gene , accounts for two a4 integrin-binding sites on each VCAM-1 molecule (Osborn et al. 1992) . Alternative RNA splicing can result in forms with only one ~4 integrin-binding site.
VCAM-1 is expressed on a variety of vascular and nonvascular cells, where its primary function is to mediate intercellular adhesion. On vascular endothelium, expression is inducible by cytokine activation and VCAM-1 promotes ~4-integrin-bearing leukocyte adhesion (Carlos et al. 1990; Rice et al. 1991) . In vivo endothelial cell expression of VCAM-1 is found in a variety of inflammatory and immune conditions, including atherosclerosis O'Brien et al. 1993) and allograft rejection (Briscoe et al. 1991) , and in these settings, VCAM-1 is thought to participate in mediating ~Corresponding author. inflammatory leukocyte recruitment. In addition to endothelium, inducible expression of VCAM-1 is found in vascular smooth muscle cells (Li et al. 1993) . VCAM-1 is constitutively expressed on lymphoid dendritic cells, where it is involved in B-lymphocyte adhesion and may participate in the formation of lymphoid follicles (Freedman et al. 1990 ). On antigen-presenting cells (dendritic and endothelial cells), VCAM-1 may act as a T-cell costimulatory molecule (Burkly et al. 1991; Damle and Aruffo 1991; van Seventer et al. 1991) . Expression on bone marrow stromal cells may contribute to the maturation of hematopoietic cells (Miyake et al. 1991; Simmons et al. 1992} .
As in inflammation, intercellular adhesion is thought to be important in cellular migration and organization during embryonic development. Antibody-blocking studies have revealed a role for E-cadherin in preimplantation blastocyst compaction and cavitation (Damsky et al. 1983) , which has been confirmed by targeted disruption of the murine E-cadherin gene (Larue et al. 1994) . Similarly, a wide variety of integrins and extracellular matrix ligands have been implicated in trophoblast differentiation and invasion (Damsky et al. 1993) . VCAM-1 has only been implicated in later events during development. Through its interactions with ~4 integrins, it has been shown to participate in secondary myogenesis (Rosen et al. 1992) . VCAM-1 expression has been de-
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scribed in the developing mouse myocardium and muscularis of the stomach, leading to speculation regarding its possible involvement in cardiac and alimentary development (Sheppard et al. 1994) .
Most research on placentation has focused on cellular events involving trophoblast invasion of the uterus (Welsh and Enders 1993) , immunological matemal-fetal interactions (Kovats et al. 1990) , and changes produced in the matemal vasculature as a result of implantation (Ogura et al. 1991) . Conversely, little is understood regarding the development of the fetal placental vascular system from undifferentiated fetal allantoic mesoderm (Pijnenborg et al. 1981) . The complexity of the definitive hemochorial placenta in rodents and humans is comparable to the other developing embryological systems (i.e., cardiovascular, urogenital, etc.) and implies a precise orchestration of cellular adhesion and migration.
In this study we provide new insights into the mechanism of placentation and umbilical cord formation. Using homologous recombination in embryonic stem (ES) cells, we inactivated the murine VCAM1 gene and determined an essential and novel role for VCAM-1 in embryogenesis--fusion of the allantois to the chorion. This mid-gestational event is required for umbilical cord and placental development and is necessary for maternalfetal nutrient/gas exchange and, ultimately, for intrauterine survival.
Results

Generation of VCAM-l-deficient mice
The murine VCAM1 gene was disrupted by homologous recombination in ES cells (Thomas and Capecchi 1987; Mansour et al. 1988; McMahon and Bradley 1990) . The strategy was to delete most of the first immunoglobulinlike domain, critical to VCAM-1 function (Osborn et al. 1992) . Alternatively spliced forms of VCAM-1 lacking domain 1 have not been observed. The VCAM1 gene was cloned from a J1 ES cell genomic library , and a targeting construct was assembled from a 6.7-kb EcoRI genomic clone at the 5' portion of the gene containing the core promoter and the first four exons encoding the signal peptide and immunoglobulin-like domains 1-3 (Fig. 1A) . Exon 2, encoding domain 1, was disrupted by deleting the majority of this domain and a portion of the following intron with restriction enzymes BglII and NheI. At this site, a neomycin resistance cassette (NEO) was inserted in the opposite transcriptional orientation to VCAM1. Homologous regions of the [AI VCAM1 wild-type allele, targeting construct, and targeted homologous recombination at the VCAM1 locus. The targeting construct was assembled from a 6.7-kb EcoRI genomic clone containing the first four exons (11) . The majority of the first immunoglobulin-like domain (D1) and a portion of the following intron were removed by BglII and NheI restriction enzymes and replaced by the NEO cassette in the opposite transcriptional orientation to VCAM1. A herpes simplex virus TK cassette was inserted at the 5' end, and the construct was linearized by digestion with NotI. ([3) Probes used for Southern blotting. (B} BamHI; (RI) EcoRI; (X)XhoI. (B) Representative lanes from Southern blots of DNA obtained from expanded ES cell clones. The 5' probe {0.5-kb EcoRI-PstI fragment) was used to screen G418-resistant colonies for targeted homologous recombination at the VCAM1 locus. The 7.0-and 5.0-kb bands represent the wild-type and targeted alleles, respectively. Single integration of the targeting construct was verified with a NEO probe (8.7-kb band), and appropriate integration at the 3' end was confirmed with a probe 3' to the targeting construct (12.3-kb band) . Arrowheads indicate lanes with targeted homologous recombination. respectively. For negative selection against random integration of the targeting construct, a herpes simplex virus thymidine kinase (TK) cassette was inserted at the 5' end of the construct (Mansour et al. 1988) .
The linearized targeting construct was electroporated into murine J1 ES cells (Li et al. 1992) , and ES cells were selected using G418 and the pyrimidine analog FIAU (McMahon and Bradley 1990) . Homologous recombination frequency at a single VCAM1 allele was 7.6% (13 of 170 antibiotic-resistant ES cell colonies), determined by Southem blotting (Fig. 1B) . Single integration of the targeting construct and appropriate recombination at the 5' and 3' ends were verified by Southern blotting (Fig. 1B) . Seven mutant clones were injected into C57BL/6 and BALB/c recipient blastocysts, and male offspring exhibiting extensive coat chimerism (founder males) were subsequently mated to wild-type C57BL/6, BALB/c, and 129 females. Germ-line transmission of the disrupted VCAM1 allele was achieved for the first three clones injected (V16, V44, and V80), and these were used for the remainder of the study. F1 mice heterozygous for the disrupted VCAM1 allele appeared phenotypically normal (size, general health, fertility, and longevity of >1.5 years) in all three backgrounds.
Mice homozygous for the disrupted VCAM1 allele die during mid-gestation
Mating of F 1 and F2 mice heterozygous for the disrupted VCAM1 allele in the 129/C57BL/6, 129/BALB/c, and pure 129 strains revealed a striking paucity of homozygous VCAM-l-deficient mice surviving at term {<1% total), indicating a recessive lethal phenotype (Table 1) . Genotyping of embryos derived from timed pregnancies demonstrated an alteration in the expected Mendelian distribution. Instead of 25%, a decreased number of VCAM-l-deficient embryos was found by 12.5 days postcoitum (p.c.) or earlier, accompanied by an increased number of phenotypic abnormalities and necrotic implantation sites (Table 1 ). All 12.5 days p.c., VCAM-1-deficient embryos showed histologic evidence of cell death and tissue necrosis. These data indicated that absence of VCAM-1 results in mid-gestational demise of embryos.
Absence of chorioallantoic fusion in VCAM-l-deficient embryos
In VCAM-l-deficient embryos, the sequence of events following implantation, including gastrulation and neu- rulation, proceeded normally. However, at 8.5 days p.c., a failure of fusion of the embryonic allantois to the chorion occurred in VCAM-l-deficient embryos ( Fig.   2A ). By 9.0-9.5 days p.c., an unfused allantois underwent marked hydropic expansion and this distinct phenotype was clearly evident {Fig. 2B). The embryos turned normally, and no other developmental defects were found at this stage (Fig. 2C) . Connection to the yolk sac vasculature via vitelline vasculature was normal, as was yolk sac blood vessel formation and hematopoiesis. Subsequently, hydropic allantoides became compact, embryos died within 1-3 days, and began resorbing. Despite the absence of chorioallantoic fusion in VCAM-l-deficient embryos, the allantoic mesoderm was able to differentiate into vascular structures (Fig. 2D) .
In wild-type embryos, mesenchyme derived from the posterior primitive streak forms the allantois, which grows from the caudal region of the embryo across the exocoelomic cavity toward the chorionic plate (Theiler 1989) . The allantois fuses with the chorion at 8.0-8.5 days p.c., and, subsequently, the allantoic mesoderm forms the embryonic vasculature of the developing placenta (Rossant and Croy 1985) . The mesoderm of the allantoic stalk differentiates to form an umbilical cord containing arterial and venous blood vessels. In VCAM-1-deficient embryos, the absence of chorioallantoic fusion prevented matemal-embryo respiratory and nutritional exchange and resulted in embryonic death within 1-3 days. A similar outcome has been observed in embryos with agenesis or hypogenesis of the allantois and, thus, absent chorioallantoic fusion (Chesley 1935; Valshtrem 1960; Vickers 1985) .
Immunohistochemical staining performed on 8.0-to 8.5-day p.c. wild-type embryos, immediately prior to chorioallantoic fusion, revealed expression of VCAM-1 on the tip of the allantois and ~4 integrin on the inner surface of the chorionic plate (Fig. 3) . The cuboidal cells lining the surface of the allantois appeared to be expressing VCAM-1, whereas the inner mesenchymal-like cells did not. These data suggest that VCAM-1 on the tip of the allantois can interact with ~4 on the chorionic surface to mediate chorioallantoic fusion.
At 8.5-9.5 days p.c., the only tissue in wild-type embryos with VCAM-1 expression other than the allantois was the heart, where VCAM-1 was expressed by myocytes of the developing myocardium. Immunohistochemical staining was utilized to demonstrate absence of VCAM-1 protein expression in 9.5-day VCAM-1-deficient embryos, which were identified by an unfused hydropic allantois and by genotyping of yolk sacs {data not shown). Expression of (x4 integrin was not detected in the heart at this time. 
Role of VCAM-1 in placental formation after chorioallantoic fusion
All embryos of timed pregnancies summarized in Table  1 were carefully dissected with particular attention given to determine whether chorioallantoic fusion had occurred. In the 129/C57BL/6 background, chorioallantoic fusion was found in 17% of VCAM-l-deficient embryos, and in the 129 background, the frequency was 9% (Table 1) . None were found in the 129/BALB/c background. Fused VCAM-l-deficient embryos appeared to develop and survive 1-2 days longer than VCAM-1-deficient embryos without chorioallantoic fusion; however, at 12.5 days p.c. they were dead. Histologic sections through these embryos showed extensive tissue necrosis, precluding detailed analysis of organs (not shown). Because, in mid-gestational embryos, VCAM-1 is expressed during placentation and in the developing heart, the possibilities of placental or cardiac defects were investigated.
In wild-type embryos, we observed that within hours of chorioallantoic fusion, the allantoic mesoderm covered the entire placental surface. The fused allantois assumed a funnel configuration containing a large hydropic space (Fig. 4A ). This is in agreement with descriptions of this process published previously (Ellington 1985) . Immunohistochemical staining shortly after chorioallantoic fusion revealed VCAM-1 expression in the allantoic mesoderm in contact with the chorionic plate and surrounding the hydropic space (Fig. 4B ), and in a serial section, c~4 expression was found on the chorionic surface (Fig. 4C ). These expression patterns suggest that VCAM-1/a4 integrin interactions may be necessary for the efficient distribution of allantoic mesoderm over the entire placental surface. The significance of this is that the allantoic mesoderm subsequently differentiates into arborizing vascular channels, which are connected to umbilical vessels (Cinquetti 1983) , and invades the trophoblast, forming embryonic blood vessels of the hemochorial placenta (Mossman 1987) . A delay in placental formation may have deleterious effects on embryonic development, leading to embryonic defects and even death. The above hypothesis was supported by observations in 10.5-and 11.5-day embryos.
In 10.0-to 10.5-day wild-type and heterozygous embryos, the hydropic space in the allantois was largely resorbed and blood vessel formation was evident in the allantoic mesoderm adjacent to trophoblasts (Fig. 5A,B) . In a VCAM-1-deficient littermate, we found an allantois attached to the chorion, with morphologic features suggesting that the hydropic change occurred prior to fusion (Fig. 5A, C) . The allantoic mesoderm was not distributed over the entire chorionic surface, and formation of vascular structures lagged in comparison with a heterozygous littermate. Although a central umbilical blood vessel was present, only focal mesodermal invasion was seen at regions where the mesoderm was in contact with the chorion. These features represent a developmental delay of the placenta with respect to the embryo.
At 11.5 days p.c. we found viable VCAM-l-deficient embryos, both with and without chorioallantoic fusion (Table 1 , 129 strain). Thin sections revealed delayed development of the placenta in a VCAM-l-deficient embryo (Fig. 6) . Unlike wild-type and heterozygous littermates, there was minimal invasion of the placental trophoblast layer by allantoic mesoderm and embryonic blood vessels were virtually absent in the trophoblast.
All viable VCAM-1-deficient embryos also had cardiac abnormalities. Sections showed vacuolation, blebbing, cell rounding, and dissolution of the epicardial layer (Fig.  7) . The adjacent thoracic wall appeared normal, and mitotic figures were seen occasionally. Variable vacuolation, blebbing, and rounding were seen in myocardial and endocardial cells, predominantly in embryos without chorioallantoic fusion (not shown). In wild-type and heterozygous littermates, the epicardium and endocardium consisted of a uniform sheet of flat cells (Fig. 7) .
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Cold Spring Harbor Laboratory Press on October 19, 2017 -Published by genesdev.cshlp.org Downloaded from Figure 4 . VCAM-1 and a4 integrin expression in wild-type embryos after chorioallantoic fusion. {A) Section of an 8.5-day embryo stained with hematoxyllin and eosin, showing spread of allantoic mesoderm over most of the chorionic surface shortly after chorioallantoic fusion. The allantois has a funnel configuration and contains a central hydropic space {HS). {AL) Allantois; (AM) amnion; (CH} chorion; (T)trophoblast; (EH) embryo head; (UD) uterine decidua; {YS)yolk sac. Bar, 100 ~m. (B)An embryo at a similar developmental stage stained with mAb MK-2. VCAM-1 expression is found in the allantoic mesoderm in contact with the chorion and surrounding the hydropic space. A littermate of this embryo, which had not undergone chorioallantoic fusion, is shown in Fig. 3 . Bar, 100 ~tm. (C) A serial section showing o~4 integrin expression (PS-2 staining) at the junction of allantoic mesoderm and chorion. Intense staining is seen in a cell layer immediately adjacent to the hydropic space (arrowheads), whereas intense VCAM-1 staining is below this (B), suggesting that the cells expressing c~4 are derived from the chorion and that the allantoic mesoderm may have penetrated through this layer. At the edges of the chorion not in contact with allantoic mesoderm, ~4 integrin expression is found on the surface. Other tissues within the embryo also express ~4. Bar, 100 izm.
Analysis of viable VCAM-l-deficient mice
In >300 offspring of Ft and F2 heterozygous matings, three viable VCAM-l-deficient mice were identified by Southern blotting of tail DNA. These mice were males, fertile, and indistinguishable in size, weight, general health, activity, and longevity from wild-type or heterozygous littermates. On two occasions during mating, one of the VCAM-l-deficient males developed skin wounds on the back, and these healed readily. The homozygous VCAM-l-deficient male mice were bred with heterozygous females, and of 95 offspring in these litters, an additional VCAM-l-deficient male was identified; all the remaining offspring were heterozygous. When 9.5-day p.c. embryos produced by these matings were examined, the expected Mendelian distribution and chorioallantoic fusion defect were found.
In addition to Southern blot analysis of tail DNA, PCR analysis of blood samples and a portion of the ear was performed on all four VCAM-l-deficient mice and a wild-type VCAM1 allele was not detected (data not shown). To further exclude the possibility of genetic mosaicism in these mice, two were injected with lipopolysaccharide [LPS, 100 ~g intraperitoneal (i.p.)] 4 hr prior to sacrifice. Various organs were harvested and subjected to Southern blot and PCR analysis that detected only the mutated VCAM1 allele (Fig. 8A) . Northern blot analysis of RNA revealed the absence of VCAM-1 transcript in VCAM-l-deficient mice and reduced transcript in heterozygotes (Fig. 8B) . Immunohistochemical staining did not detect VGAM-1 protein in the heart, spleen, or lung, although intercellular cell adhesion molecule-1 (ICAM-1) expression appeared normal (Fig. 8C-F) . Hearts of VCAM-l-deficient mice had normal chamber anatomy and distribution of coronary arteries. Histologic sections showed normal epicardium, myocardium, and endocardium (Fig. 7C ). Gross and histologic examination of other organs, including skeletal muscle and spleen, did not reveal any abnormalities.
Analysis of circulating leukocytes obtained from orbital blood of VCAM-l-deficient mice revealed an elevated total leukocyte number as compared with wildtype and heterozygous mice (P<0.05). Differential counts determined that this was the result of elevated mononuclear leukocytes, whereas numbers of circulating granulocytes were comparable (Table 2 ).
D i s c u s s i o n
Essential role for VCAM-1 in chorioallantoic fusion
The data presented here demonstrate a novel and essential role for VCAM-1 during embryonic development in
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mice. In >80% of VCAM-l-deficient embryos, the complete absence of chorioallantoic fusion resulted in embryonic demise by 10-12 days p.c. (Fig. 9) . Death was caused by the absence of placental formation, which was established at this time in wild-type embryos (Mossman 1987; Kaufman 1992) . Similar results were observed in VCAM-1-deficient mice derived independently by Kwee et al. (1995) . Normal embryonic development of viviparous m a m m a l s is dependent on the establishment of an efficient maternal-fetal exchange mechanism. Failure of chorioallantoic fusion is a common, though poorly understood, cause of mid-gestational demise. In rodents it can be induced by a variety of agents, including radiation -, left) has a normal umbilical cord and blood vessel {arrow), whereas the homozygous VCAM-l-deficient embryo ( -/ -, right) has a hydropic space surrounding a centrally located vascular structure {ar-row). (B) Toluidine blue-stained 2-~m methacrylate section of the placenta from the heterozygous embryo in A, shows allantoic mesoderm spread over the entire placental region (between arrowheads). An umbilical vessel (UV) is present, and blood vessels {arrows), which are derived from the allantoic mesoderm, are found adjacent to the trophoblast. The allantoic mesoderm is invading the trophoblast extensively.
(C] The placenta from the VCAM-1-deficient littermate shows a hydropic allantois attached to the chorion. In these regions, allantoic mesoderm is invading into the trophoblast {arrows). The allantoic mesoderm is not distributed over the entire placental surface, and although a central umbilical blood vessel is seen, vascular structures are not evident over the trophoblast. These features represent a placental developmental delay with respect to the embryo. Bars, 100 ~m. (Kuznetsova 1957; Valshtrem et al. 1960) , hypothermia (Tripolskaya et al. 1961) , and various pharmaceuticals, such as cyclophosphamide, azaserine (Murphy and Karnovsky 1956) , and retinoic acid (Vickers 1985) . This m a y reflect the susceptibility of allantoic mesoderm, w h i c h in the period surrounding chorioallantoic fusion is the most rapidly growing and dividing tissue in the developing embryo, to the disparate actions of a variety of agents. In the majority of m a m m a l s , chorioallantoic placentation is the only m e c h a n i s m for maternal-fetal exchange, and its disruption is universally lethal. The localized expression of VCAM-1 on the allantois and ~4 integrin on the chorion during chorioallantoic fusion and placentation suggests that VCAM-1 interacts with its known ligands, ~4~1 and/or e,4~7, during this process. This was confirmed by observations in a4-deficient mice, where a morphologically similar chorioallantoic fusion defect was found (Yang et al. 1995) . Receptorligand pairs other than VCAM-1/et4 integrins m a y also contribute to chorioallantoic fusion, as fusion occurred in a subset of both VCAM-1-and e~4-deficient embryos.
During chorioallantoic fusion, VCAM-1 interactions with e~4 integrins m a y be important in several ways. Adhesive interactions m a y direct allantoic attachment to the chorion, located on the well-vascularized mesometrial aspect of the uterus, and not to the adjacent yolk sac, as occurs in cultured embryos w h e n the chorion is removed (Fujinaga and Baden 1993) . Likewise, VCAM-1 expression on the tip of the allantois m a y selectively promote fusion of this region. It is also possible that VCAM-1 binding to ~4 m a y initiate cell signaling in the chorion. Our data indicate that VCAM-1/~4 interactions are not required for the initiation of two distinct allantoic events, which occur following chorioallantoic fusion--hydropic change and mesodermal vascular differentiation--suggesting that other molecular signals are responsible.
VCAM-1 in early placental formation
We have also demonstrated that following chorioallan-
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Cold Spring Harbor Laboratory Press on October 19, 2017 -Published by genesdev.cshlp.org Downloaded from Gurmer et al. Figure 6 . Placental developmental delay in a l l.5-day VCAM-1-deficient embryo. Methacrylate sections of l l.5-day heterozygous (A,C) and VCAM-l-deficient (B,D) littermates are shown. The placenta of the heterozygous embryo ( + / -) has a well-established labyrinth layer (L; shown in detail in C), allowing maternal-embryo exchange. Abundant embryonic blood vessels (arrowheads) have penetrated deep into the trophoblast (T). These vessels are lined by embryonic endothelial cells with a well-developed basement membrane, contain nucleated erythrocytes, and are adjacent to maternal vascular channels (A). Maternal vascular channels lack endothelium, are lined by trophoblast cells, and contain maternal erythrocytes. Sections of placenta from the VCAM-l-deficient embryo ( -/ -) show delayed placental development. Although the allantoic mesoderm (ALM) covers the trophoblast (T) and contains vascular structures (arrowheads), there is only minimal invasion of the placental trophoblast layer by allantoic mesoderm and embryonic blood vessels are virtually absent in the trophoblast. Thus, a placental labyrinth layer has not been established. Spaces in the trophoblast are forming maternal vascular channels (A), and some contain maternal erythrocytes. (UV) Umbilical vessels; (UD) uterine decidua. Bar, 100 ~m.
toic fusion, VCAM-1 is necessary for the efficient distribution of allantoic mesoderm over the entire placental surface. This is an early step in the formation of the placenta and is necessary for normal placental development. The exact role of VCAM-1 in this process is not clear. Adhesive interactions with 0~4 integrins, expressed over the entire chorionic surface, may act as a "molecular zipper" approximating the allantoic mesoderm to the chorion. These adhesive interactions may allow lateral movement of the allantois on the chorion, resulting in a symmetrical distribution of allantoic mesoderm and evenly distributed placental vasculature. Mechanical forces generated by hydropic swelling of the distal end of the allantois (Ellington 1985) may aid in bringing the allantois into contact with the entire chorionic surface.
In a minority of VCAM-1-deficient embryos, the allantois was able to fuse to the chorion (Fig. 9) ; however, placental abnormalities were found at 10.5 and 11.5 days gestation and these embryos died by 12.5 days. At 10.0-10.5 days gestation, the allantoic mesoderm was not distributed over the entire chorionic surface, and at 11.5 days, embryonic vascular invasion of the trophoblast layer was minimal. With respect to other organs, these placentas were developmentally delayed, and consequently, the inadequate placental maternal-embryo exchange may have caused developmental defects and subsequent embryonic death. Two possibilities may explain the observed phenotype. If the distal end of the allantois had fused to the chorion at the appropriate time (at 8.5 days p.c.), the absence of VCAM-1/a4 integrin adhesive interactions could have resulted in abnormal distribution of the allantoic mesoderm over the chorion and delayed placental development. Alternatively, delayed chorioallantoic fusion and hydropic expansion of the allantois prior to fusion could have contributed to the defects. It is also possible that morphologically inapparent functional defects in placental physiology may have existed. These could include alterations of the interhemal diffusion barrier, dysfunctional regulation of vascular tone, or disruption of the maternal-fetal countercurrent exchange system, all of which could result in embryonic death (Metcalfe et al. 1967; Schroder 1982) .
In l l.5-day viable VCAM-l-deficient embryos both with and without chorioallantoic fusion, we found epicardial changes that were similar to those in o~4-deficient embryos (Yang et al. 1995.) . These consisted of epicardial cell vacuolation, swelling, and focal dissolution. The epicardial changes may have been the result of the absence of VCAM-1 expression in the myocardium or secondary to abnormal or delayed placentation, which we found in these and in 10.5-day embryos. Others have reported cardiac defects secondary to inadequate maternal-fetal exchange. For example, Brachyury embryos, homozygous for mutant T alleles, have defects in mesoderm formation and agenesis of the allantois (Stott et al. 1993) . Although the T gene is not expressed during cardiac devel- opment (Wilkinson et al. 1990) , embryos have delayed development of the heart and an enlarged blood-filled pericardial cavity prior to mid-gestational embryonic death (Chesley 1935) .
Viable VCAM-l-deficient mice
We have identified four surviving homozygous VCAM-1-deficient mice, which, with the exception of a selective mononuclear leukocytosis, appear phenotypically similar to littermates. Their organs did not reveal any gross or histologic abnormalities, including those in which VCAM-1 has been postulated to play a developmental role, such as skeletal muscle and heart (Rosen et al. 1992; Sheppard et al. 1994) . If more than one VCAM-1-dependent process is critical to development, the existence of four viable VCAM-l-deficient mice makes it statistically unlikely that a number of infrequent "escape events" serendipitously coincided in these animals. A more likely possibility is that except for placentation, VCAM-1 is not necessary for the normal growth and development of tissues in which it is expressed.
All four surviving VCAM-1-deficient mice were fertile males; however, small numbers preclude conclusions as to whether this sex distribution is significant. The elevated levels of circulating mononuclear leukocytes suggest that VCAM-1/a4 integrin interactions may be involved in the homeostatic regulation or clearance of these leukocytes. Analogous elevation in numbers of circulating granulocytes have been described in null mutations for other adhesion molecules, including P-selectin and ICAM-1 (Mayadas et al. 1993; Sligh et al. 1993; Xu et al. 1994) . Despite this abnormality, VCAM-l-deficient mice appeared healthy.
An unresolved question is how -3 % of VCAM-I-deficient embryos survived embryonic development. Several possibilities may account for this. One was that some VCAM-l-deficient embryos were able to achieve chorioallantoic fusion and form a placenta with sufficient function to allow survival. Another was that maternally derived soluble VCAM-1 may have diffused into the developing embryo, as has been described in transforming growth factor-~ (TGF-~)-deficient mice tLetterio et al. 1994), was adsorbed onto the allantois, and "rescued" some of the VCAM-1-deficient embryos. Our pilot experiments directed at augmenting soluble maternal VCAM-1 levels by injecting pregnant mice on day 6.5 p.c. with LPS (1 ~g i.p.) did not succeed in increasing the survival of VCAM-1-deficient embryos (data not shown}.
Because VCAM-l-deficient embryos form normal vitelline vasculature, it is possible that some of them survived by relying partially on a secondary form of placentation unique to rodents, the inverted yolk sac placenta. Because of embryonic turning, developing rodent embryos are enveloped within an extremely well-vascularized inverted yolk sac, which is in direct contact with a large surface area of the uterine decidua (Jollie 1990) . This is the primary form of matemal-fetal respiratory exchange until it is superseded by the chorioallantoic placenta (Mossman 1987) . Although not invasive, as the definitive chorioallantoic placenta is, it is involved in the acquisition of maternal antibodies (Brambell 1957}, vitamin B12 (Padykula et al. 1966 , and amino acids . The importance of yolk sac placentation in rodent development is demonstrated by the observations that intrauterine ligation of vitelline vessels in rats results in embryonic death (Noer and Mossman 1947) and that administration of polyclonal or monoclonal antibodies directed against yolk sac antigens can lead to severe teratogenicity and embryonic demise (Brent et al. 1990 ). This proposed mechanism may also explain the chronological spectrum of embryonic death that we observe in embryos without chorioallantoic fusion. Our observations may have important implications for human health and disease. Administration of anti-VCAM-1 therapeutics to mothers for inflammatory or immune conditions during the early stages of pregnancy could have dire deleterious consequences for the developing embryo by preventing chorioallantoic fusion in the third week of gestation (Pijnenborg 1981) VCAM-1/a4 integrin interactions in humans 2--4 weeks after conception may be a way to terminate pregnancy. It is also conceivable that defects in VCAM-1/a4 interactions may be one of the myriad causes of recurrent spontaneous first trimester abortions and resultant infertility. Because placentation is critical to normal embryonic development, abnormalities of this process can have fatal or life-long consequences. Impaired placental vascularization is believed to be important in acute and chronic placental insufficiency, a major though poorly understood cause of perinatal morbidity and mortality (Fox 1978) . In view of the crucial role of VCAM-1 in chorioallantoic fusion and early placental development, it is possible that mutations or deficient expression of the VCAM1 gene can contribute to the pathogenesis of a subset of human placental insufficiencies.
Materials and methods
Assembly of VCAM1 targeting construct
Genomic DNA corresponding to the 5' portion of the murine VCAM1 gene was isolated from a J1 ES cell genomic library kindly provided by Drs. Hong Wu and Rudolf Jaenisch (Whitehead Institute for Biomedical Research and Massachusetts Institute of Technology, Cambridge, MA) ).
The targeting construct was assembled from a 6.7-kb EcoRI fragment, containing the core promoter, the signal peptide, and immunoglobulin-like domains 1-3. A 0.4-kb fragment between restriction enzyme sites BglII and NheI, which included the majority of domain 1 (exon 2) and a portion of the following intron, was replaced with a NEO cassette in the opposite transcriptional orientation to VCAM1 (Fig. 1A) . The neomycin resistance gene was flanked by the murine phosphoglycerate kinase-1 (PGK-1) promoter and the PGK-1 3'-untranslated region with polyadenylation signal (McBurney et al. 1991) . Homologous regions 5' and 3' of NEO were 2.0 and 4.3 kb, respectively. For negative selection against random integration, a herpes sireplex virus TK gene, flanked by a mutant polyoma virus enhancer (pMC1-TK; TK) was inserted at the 5' end of the construct in the 5' to 3' orientation (Mansour et al. 1988) . A unique NotI restriction site in the pBluescript II KS vector polylinker (Stratagene) was used to linearize the construct for transfection of ES cells. Ligation sites in the targeting construct were verified by restriction enzyme digestion and nucleotide sequencing.
Growth, transfection, and selection of targeted ES cells
J1 ES cells, derived from 129/terSv mice (Li et al. 1992) , were grown on irradiated embryonic feeder cells in HEPES-buffered (20 mM at pH 7.3) Dulbecco's modified Eagle medium (DMEM) supplemented with 15% fetal bovine serum, 0.1 mM nonessential amino acids (GIBCO), and 0.1 mM 2-mercaptoethanol. The cells were refed daily. Feeder cells were derived from day 14 embryos and carried the neomycin resistance gene. ES cells were electroporated (1 x 107 cells/ml, 25 ~F, 400 V, 22°C) with 25 ~g/ml of linearized DNA and plated in 100-mm dishes {3x106 cells/dish) on neomycin-resistant embryonic feeder cells. Antibiotic selection was initiated after 24 hr with G418 (400 ~g/ml; GIBCO-BRL), followed by G418 and FIAU (0.2 ~M, Eli Lilly) at 48 hr. One plate was selected with G418 alone, allowing estimation of threefold enrichment obtained by FIAU selection. Doubly resistant colonies with appropriate morphologic features were picked 8-10 days after plating, dissociated with trypsin-EDTA, and transferred to 24-well plates, where they were grown without further antibiotic selection. After 3--4 days, half the cells in each well were frozen and DNA was extracted from the remainder.
Generation and breeding of chimeric mice
Prior to microinjection, ES cell clones carrying the targeted homologous recombination event at one VCAM1 locus were expanded on embryonic fibroblast feeder cells. ES cells (20) (21) (22) (23) (24) (25) were microinj ected into 3.5-day C57BL / 6 or BALB / c blastocysts and surgically implanted into uteri of pseudopregnant foster mothers (2.5 days p.c. with vasectomized males). Pups born 17 Figure 9 . Spectrum of chorioallantoic fusion/placentation defects in VCAM-I-deficient mice.
Cold Spring Harbor Laboratory Press on October 19, 2017 -Published by genesdev.cshlp.org Downloaded from days after injection were identified as chimeric on the basis of agouti coat pigmentation, which was apparent 8-10 days after birth. Chimeric males were mated at 6 weeks of age with C57BL/6 or BALB/c females. Germ-line transmission was determined by the presence of agouti coat pigmentation in the F 1 animals, and tail biopsies were obtained from these mice for genotyping.
Isolation of DNA, Southern blotting, and polymerase chain reaction DNA for Southern blotting and polymerase chain reaction (PCR) was isolated by proteinase K digestion and precipitation with isopropanol (Laird et al. 1991) . For yolk sacs and mouse tissues other than tails, a phenol/chloroform (50:50) extraction was included prior to precipitation of DNA. DNA was redissolved in Tris--EDTA buffer.
For Southern blotting, genomic DNA (-10 ~g) was subjected to restriction enzyme digestion, electrophoresed through 0.8% agarose gels, and transferred to a BioTrans + (ICN) nylon membrane (Sambrook et al. 1989 ). Blots were hybridized at 65°C with DNA probes labeled with [~-32p]dCTP (DuPont-NEN) using random sequence decanucleotide primers {Amersham). Autoradiography with enhancing screens was performed at -80°C.
PCR was performed to genotype embryo yolk sacs and tissues from VCAM-l-deficient adult mice. PCR primers were selected to generate a product specific for either the wild-type or the mutant VCAM1 alleles. Two PCR reactions were performed on each DNA sample and electrophoresed in adjacent lanes. For the wild-type allele, a 0.37-kb PCR product was generated by primers: CCAGCTGTGCTTTGGACACT (located in VCAM1 intron 1) and complementary to TGTGGCTCTGGGTTGCTG, a region of VCAM1 exon 2, which was deleted in the mutant allele. A 0.38 kb PCR product was generated by primers for the mutant VCAM1 allele: CAGCTGTGTTTGGACACTG {in VCAM1 intron 1) and CCAGCTCATTCCTCCACTCAT (in PGK 3'-untranslated region of the NEO cassette). In wild-type mice, a PCR product was found only with primers to the wildtype VCAM1 allele; both PCR products were found in heterozygous mice, and only the PCR product generated by primers to the mutant allele was found in homozygous VCAM-1-deficient mice. Positive and negative controls were run with each analysis and consisted of DNA genotyped by Southern blotting and water. PCR reactions were 30 cycles of denaturation at 94°C for 1 sec and 92°C for 29 sec, annealing at 55°C for 30 sec and extension at 72°C for 60 sec, with a final 8-rain extension. The PCR reaction volumes were 50 ~1 and contained 30 pmoles of each primer, 0.25 units of Taq DNA polymerase (Perkins-Elmer Cetus), and 1.5 mM MgC12. PCR products were resolved by 1.5% agarose gel electrophoresis.
Northern blotting
Total cellular RNA was isolated from tissues by 4 M guanidine isothiocyanate followed by centrifugation through a cesium chloride gradient {Sambrook et al. 1989) . Equal amounts of RNA (10 ~g/lane) were electrophoresed through a 1% agarose gel containing formaldehyde, transferred by capillary action to a nylon membrane {BioTrans +, ICN), and hybridized overnight (65°C in buffer containing 5% SDS; Virca et al. 1990 ) with a 32P-labeled eDNA probe to rat VCAM-1 {1.8 kb, spanning from immunoglobulin-like domain 2 to the cytoplasmic domain). After stripping, the blot was reprobed with a cDNA probe to rat tubulin.
Timed pregnancies and dissection of embryos
Timed pregnancies were performed essentially as described by Rugh (1968) . Pregnant female mice were sacrificed, and uteri were removed immediately via an abdominal midline incision. The uteri were immersed in phosphate-buffered saline (PBS), and embryos were dissected under a Nikon SMZ-U stereoscopic zoom microscope equipped with a photographic adapter. Particular attention was given to determine whether chorioallantoic fusion occurred and to examine the placental region. All abnormal embryos were photographed adjacent to normal-appearing littermates. Yolk sacs were dissected for genotyping (7.5 and 8.5 day genotyped by PCR; 8.5 day and older by Southern blotting) and embryos were stored in 10% buffered formalin.
Histologic and immunohistochemical techniques
Methacrylate embedding and sectioning were performed as described by Beckstead et al. (1981) , with minor modifications. Embryos were fixed with 10% buffered formaldehyde, dehydrated through a series of graded acetone mixtures, and embedded in glycol methacrylate (JB-4 Plus, Polysciences, Inc.). Sections 2 ~m in thickness were cut with a glass knife on a LKB ultramicrotome, stained with 0.5% toluidine blue/1% sodium tetraborate, and coverslipped with Permount.
Immunohistochemical staining was performed essentially as reported previously . Embryos were fixed with 2% paraformaldehyde for 2 hr, equilibrated with 8% then 18% sucrose in PBS, embedded in OCT compound, and snap-frozen in liquid nitrogen-cooled 2-methylbutane. Adult mouse tissues were embedded fresh in OCT compound. Tissues were stored at -80°C. Serial sections were cut on a cryostat, adhered to Vectabond-coated slides, air dried, and fixed for 5 min in acetone at -20°C. Sections were sequentially incubated for 1 hr with primary antibody (1:10 dilution of tissue culture supernatant), biotinylated rabbit antirat IgG (1:200 dilution, Vector Labs), and avidin-biotin-peroxidase complexes (ABC Elite kit, Vector Labs) diluted 1:100 in Tris-saline. After each incubation, sections were washed three times in Tris-saline, 5% newborn calf serum. Prior to incubation with avidinbiotin complexes, endogenous peroxidase activity was inactivated with 0.3% hydrogen peroxide in PBS. Peroxidase activity was detected with 3-amino-9-ethylcarbazole (Sigma), sections were counterstained with GriPs hematoxylin #2, and mounted in glycerol gelatin. Rat monoclonal antibodies to routine VCAM-1 (MK-2), ICAM-1 (YN-1), and ~4 integrin (PS-2) were obtained from the American Type Culture Collection. Nonimmune rat IgG (0.3 ~,g/ml; Caltag) was used as a negative control.
Hematological studies
Mice were anesthetized with tribromoethanol (0.3 mg/g i.p.) and bled from the retro-orbital plexus using heparinized caprilary tubes. Leukocyte counts were performed by hemocytometer after dilution of whole blood in Turk's solution (methyl violet in 1% acetic acid). Differential leukocyte counts were performed on peripheral blood smears stained with WrightsGiemsa (Harleco). At least 200 cells were counted per smear. For statistical analysis, groups were compared using an unpaired t-test, and a P value of <0.05 was used to denote significance.
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